Sign In

Ann Xu

Diabetes BU head at Boehringer Ingelheim

Ann Xu is a seasoned professional with over 15 years of ethical marketing and sales management experience in top multinational pharmaceutical companies.

She has successfully led new product launches in China, including two blockbuster pre-launches such as Plavix, and is currently overseeing the launch of another oral anti-coagulation blockbuster.

With a focus on cardiovascular and diabetes products, Ann has a diverse background in marketing and sales within the pharmaceutical industry.

Her expertise extends to team management and development, demonstrating strong leadership skills, strategic thinking, and effective execution.

She is known for her systematic planning, positive attitude, and exceptional skills in customer-oriented communication and coordination.

Ann Xu pursued her Bachelor's degree in medical studies at Shanghai Jiao Tong University Medical School.

Throughout her career, she has held key positions such as Diabetes BU head, Marketing Director, Group Product Director, Marketing Manager, and Senior Product Manager at renowned companies like Boehringer Ingelheim, Sanofi-aventis, Bristol-Myers Squibb, Sanofi-Synthelabo, and Merck Sharp & Dohme.

Highlights

Critical Care Medicine | Department of Pediatrics
Jun 1 · ana.net
Advertising Financial Management Committee | Events & Webinars

Related Questions

What is Ann Xu's role at Boehringer Ingelheim?
How did Ann Xu transition from Texas A&M to Boehringer Ingelheim?
What are Ann Xu's main responsibilities in the Diabetes BU at Boehringer Ingelheim?
What is Ann Xu's background in the field of diabetes?
How has Ann Xu's experience at ARPA-E influenced her work at Boehringer Ingelheim?
Ann Xu
Ann Xu, photo 1
Ann Xu, photo 2
Add to my network

Location

China